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1. Introduction 
Iron is essential for the metabolism and growth of 
virtually all living organisms. However, the solution 
chemistry of iron, which, in aqueous media at physi- 
ological pH-values, is dominated by the tendancy to 
oxidise and hydrolyse with formation of insoluble 
ferric hydroxides and oxyhydroxides has necessitated 
the development of specialised transport and storage 
systems for iron in biological systems. At the microbial 
level ferric iron chelators of high affinity (siderophores) 
are synthesized and excreted into the extracellular 
medium where they complex iron; the iron-sidero- 
phore complex is taken up by a receptor-mediated 
mechanism by the microbial cells, and once inside the 
cell the iron is released from the chelator, a process 
often accompanied by destruction of the ligand [ 1,2]. 
In mammalian cells iron is transported in the serum 
and in the extravascular space by transferrin, ap,-glob- 
ulin. Intracellular iron storage in many different cell 
types (including animals, plants, fungi and bacteria 
such as Azotobacter vinelandii) is assured by a spe- 
cialised protein, ferritin which consists of a hydrolysed 
polymeric ferric iron core deposited in the interior of 
a hollow protein shell (apoferritin), which maintains 
the iron in a soluble, non-toxic and bio-available form, 
from which iron can be mobilised as and when required 
by the cell. 
The best characterised mammalian iron storage 
protein is the ferritin of horse spleen. First isolated 
by Laufberger* [3] it has been the object of exten- 
sive studies since then, and remains the standard prep- 
aration for studies on iron storage and of storage iron 
deposition and mobilisation. The iron-free protein 
shell, apoferritin, has M, 440 000-480 000 [4-71 
* This article is dedicated to Professor Vilem Laufberger of 
the Charles University, Prague, Czechoslovakia 
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and is an oligomer composed of 24 polypeptide chains 
(subunits) for which 18 000-l 9 000 M, was deter- 
mined by physico-chemical techniques [7,8]. The 
apoferritin molecule is roughly spherical, of diameter 
12-13 nm, with a central cavity of diameter 6-7 nm, 
in which the iron core is deposited, mostly as Fe0 . OH, 
but with some associated phosphate [9,10]. X-ray 
crystallographic studies have resulted in an electron 
density map of the apoferritin subunit at a nominal 
resolution of 0.28 nm [ 11 ,121. The subunit can best 
be described as a parallel bundle of four a-helices 
reminiscent of a number of other proteins (haem- 
erythrin, cytochrome c’, tobacco mosaic virus, myo- 
haemerythrin, cytochrome b 562 [ 121) with two shorter 
helices situated perpendicular to them, interconnected 
by non-helical regions. 
We have been engaged in the determination of the 
primary structure of horse spleen apoferritin for some 
time [ 13,141 and we present here the complete pri- 
mary structure of the horse spleen apoferritin subunit. 
Some conclusions are presented in terms of the 
sequence and its implications for three-dimensional 
studies. 
2. Materials and methods 
Ferritin was isolated from horse spleen by a modi- 
fication of the procedure in [ 151 involving acidifica- 
tion of a tissue homogenate to pH 4.75 followed by 
(NH4)$304 (35%, w/v) precipitations and several 
recrystallisations from CdS04 (0.3 M) containing 
0.4 M NaCl [ 161. The homogeneity of the prepara- 
tions was controlled by polyacrylamide gel electro- 
phoresis in the presence and absence of sodium dodecyl 
sulphate and by amino acid analysis after hydrolysis 
for 16 h in vacua with 6 N HCl at 1 10°C, using a 
Locarte amino acid analyser (Locarte Co., London). 
Apoferritin was prepared as in [ 161. 
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Prior to cleavage with trypsin, staphylococcal pro- 
tease and chymotrypsin, apoferritin was reduced and 
carboxymethylated [ 171 and the lysine residues citra- 
conylated [ 181 in 7 M guanidine. These digests were 
fractionated by gel fdtration on Sephadex G-50 in 
0.5% (w/v) NH4HC0s and the smaller peptides were 
further purified by ion-exchange chromatography and 
by preparative paper chromatography [ 161. Since an 
Asp-Pro sequence was found in the staphylococcal 
peptide S12 we cleaved the carboxylmethylated pro- 
tein in 70% formic acid (v/v) for 4 days at 37°C and 
isolated the two fragments Pl (residues 1-122) and 
P2 (residues 123-l 74) by gel filtration on Sephadex 
G-75 in 1% (v/v) NH3 after citraconylation of their 
lysine residues [ 181. The fragment Pl was digested 
with trypsin after blocking the arginine residues with 
cyclohexanedione [ 191 in order to obtain lysyl pep- 
tides from this N-terminal fragment. Pl and I’2 were 
digested with staphylococcal protease. The products 
of these three digests were purified by gel filtration 
on Sephadex, followed by ion-exchange chromatog- 
raphy and where necessary preparative paper chro- 
matography [ 161. Carboxymethylated apoferritin 
was cleaved by CNBr in HCOOH 70% (v/v) after incu- 
bation with 3 mM dithiothreitol to reduce methionine 
sulphoxide to methionine [20]. The digest was frac- 
tionated by gel filtration on Sephadex G-75 in 1% 
NHa (v/v). The C-terminal CNBr peptide CN4 was 
digested with trypsin and the resulting peptides puri- 
fied by ion-exchange chromatography. 
The purity of peptides was established by N-ter- 
minal analysis using the dansyl chloride procedure 
[21] and by amino acid analysis. Large peptides 
020 residues) were s quenced by liquid phase Edman 
degradation i a Beckman 890 sequencer using the 
programme of [22]. After conversion of the thiazoli- 
nones to PTH amino acids identification of the latter 
was carried out by high-pressure liquid chromatog- 
raphy [22], by gas-liquid chromatography [23] and 
by thin-layer chromatography [24]. The smaller pep- 
tides were sequenced by the dansyl-Edman method 
[25] and the dansyl amino acids were identified by 
thin-layer chromatography [ 181. 
3. Results 
The complete primary structure of horse spleen 
apoferritin was deduced from the sequence of pep- 
tides obtained from the chemical and enzymatic 
cleavages in section 2. In addition to the peptides 
shown here (the chymotryptic peptides are not 
included in fig.1) a large number of peptic peptides 
were also useful in confirming the sequence given in 
fig.1. We present here the sequence together with its 
justification. 
The N-terminal arginyl peptide Tl was already 
known [26]. We isolated aninhydrin-negative, arginine- 
positive peptide of this composition as well as a 
staphylococcal protease peptide which has a composi- 
tion corresponding to residues l-l 1 and which on 
trypsin digestion gave the N-terminal blocked peptide 
and the sequence 6-l 1. A peptic peptide (4-l 1) 
confirms the overlap of Tl and T2. The arginine resi- 
dues in positions 18 and 25 were only partially cleaved, 
while the Arg-Asp bond 39-40 was resistant to 
tryptic cleavage. 
The peptides T2-T4 were isolated as an aggregated 
mixture and were sequenced as such in liquid phase. 
Their sequence as well as their order was confirmed 
by the peptides S3a and S3b (also obtained and 
sequenced as a mixture from staphylococcal protease 
digestion of Pl , presumably resulting from incom- 
plete cleavage of the Glu-Ala sequence 13-14) 
and by a number of peptic and chymotryptic peo- 
tides (not shown). The peptides S4 and S5 are impor- 
tant since they permit the alignment of T4-T6. 
A number of peptic and chymotryptic peptides were 
also isolated and sequenced in the region and confirm 
the sequence up to Leu 65. A peptic peptide was 
isolated and sequenced corresponding to the sequence 
from Glu 57-I.eu 65. The juxtaposition of T6 and T7 
thus depends olely on the Leu at position 65, but 
this’is the only order of the peptides that we have 
isolated which is consistent with the complete 
sequence. The peptide TCl , obtained from tryptic 
digestion of Pl at lysine residues, after modification 
of the arginine residues by cyclohexanedione, allow 
us to align T7-T9. The sequence of T9, determined 
by liquid phase degradation to the position 104 is 
confirmed by the staphylococcal protease peptides 
S8-SlO and by the CNBr peptide CN3. The continua- 
tion of the sequence isassured by CN3 and by a 
tryptic peptide TC2 resulting from the same disgest 
of Pl as TCl . A tryptic peptide T9b, resulting from 
cleavage of Lys 104 (which is presumably not very 
well citraconylated) confirms the sequence of CN3 
and the alignment of Sl 1 and S12. The C-terminal 
sequence is established from Pro 123 by the peptide 
P2 up to Glu 163. This sequence itself is confirmed 
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Sl 
52 _, S3b 
S3a 
T4 
, T3 
I Tl T2 
NAC-SER-SER-GLN-ILE-AR~-GLN-ASN-TYR-SER-T~~-GLU-VAL-GLU-ALA-A~~-VAL-ASN-ARG-LEU-V~~-ASN-LEU-TYR-LEU-A~~-ALA-SER-TYR-THR-T~~- 
S3b 54 , S5 , 
S3a S5a 
T4 
l 
S5b 
T3 T5 
LEU-SER-LEU-GLY-P~~-TYR-PHE-ASP-ARG-A~~-ASP-VAL-ALA-LEU-G~~-GLY-VAL-CYS-HIS-P~~-PHE-ARG-GLU-LEU-A~~-GLU-GLU-LYS-ARG-G~~- 
TCl 
56 S8 ,J 
Tb :c T7 T8 -t T9 
GLY-ALA-GLU-ARG-L~;-LEU-LYS-MET-GLN-A~~-GLN-ARG-GLY-GLY-A~~-ALA-LEU-PHE-GLN-A~~-LEU-GLN-LYS-PRO-S~~-GLN-ASP-GL"-TRP-~~Y- 
CN3 I 
TC2 F 
s9 SlO Sll 512 
T9 T9b 
THR-THR-LEU-ASP-A~~-MET-LYS-ALA-ALA-i~~-VAL-LEU-GLU-LYS-~~~-LEU-ASN-GLN-ALA-~~~-LEU-ASP-LEU-HIS-~~~-LEU-GLY-SER-ALA-~~~- 
CN3 CN4Tl , r 
T9b 
125 130 135 140 1k5 150 
ALA-ASP-PRO-HIS-LEU-CYS-ASP-PHE-LEU-GLU-SER-HIS-PHE-LEU-ASP-GLU-GLU-VAL-LYS-LEU-ILE-LYS-LYS-MET-GLY-ASP-HIS-LEU-THR-ASN- 
CN4Tl CN4T2 CN4T3 CN4T4 
P2 + 
TlO Tll 
155 160 165 170 
ILE-GLN-ARG-LEU-VAL-GLY-SER-GLN-ALA-GLY-LEU-GLY-GLU-TYR-LEU-PHE-GLU-ARG-LEU-THR-LEU-LYS-HIS-ASP 
Fig.1. Ammo acid sequence of horse spleen apoferritin. The figure includes the localisation and sequences of tryptic (T), staphylo- 
coccal protease (S) peptides and of the CNBr peptide (CN3) and the C-terminal peptide resulting from acid cleavage at residues 
122-123 (PZ). The sequences determined on 2 peptides resulting from tryptic cleavage of the fragment Pl after modification of 
the arginine residues, TCl and TC2 are also indicated as are the sequences of the 4 tryptic peptides obtained from cleavage of the 
CNBr peptide CN4 (CN4T1, etc.). A large number of peptic and chymotryptic peptides (not shown) confii the sequence. 
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Table 1 
Amino acid composition of horse spleen apoferritin 
Amino 
acid 
No. residues/subunit 
(1) (2) 
CYS 2 3.0 
Asx 18 18.5 
Thr 6 5.9 
Ser 10 9.6 
Glx 26 26.0 
Pro 2 3.0 
GlY 11 10.7 
Ala 15 15.0 
Val 8 7.4 
Met 3 3.0 
Ile 4 3.7 
Leu 28 26.4 
-fyr 6 5.3 
Phe 8 7.8 
Trp 1 2.1 
His 6 6.2 
LYS 9 9.3 
Arg 11 10.2 
The amino acid composition is given as residues of each amino 
acid per subunit of molecular weight 19 824; Column (1) 
calculated from the amino acid sequence, column (2) from 
ref. (8) 
by the staphylococcal protease peptides S12-S14 
and by peptic peptides covering the sequence 128- 
140. From Gly 145 the tryptic peptides CN4Tl- 
CN4T4 as well as the arginyl peptides TlO and Tl 1 
and the staphylococcal protease peptides S15 and 
S16, as well as a number of peptic and chymotryptic 
peptides confirm the C-terminal sequence of the pro- 
tein. 
4. Discussion 
We have established the complete amino acid 
sequence of the protein subunit of horse spleen ferritin 
and in the light of this result we consider here some 
of its implications. In the first place, we can establish 
that, compared with the amino acid composition 
(table 1) published some 10 years ago [8] there is 
excellent agreement for all amino acids except Cys, 
Pro and Trp, where in all cases the amino acid analysis 
indicated one residue more than we find in the 
sequence. This is perhaps not surprising in the case of 
Cys and Pro, but the result for Trp is disturbing, since 
it is generally accepted that the molar extinction 
coefficient of apoferritin at 280 nm (on the basis of 
the molecular mass calculated from the sequence) is 
19 500 which is in flagrant disaccord with the value 
calculated from the content Trp, Tyr and Cys in the 
sequence (13 610). It is possible that this difference 
can be attributed to the presence of a UV-absorbing 
cofactor (perhaps involved in iron reduction) with 
apoferritin, which is carried through the isolation 
procedure [27,28]. 
The apoferritin subunit based on physico-chemical 
determinations [7,8] was estimated at M, 18 500. 
This is 7% less than the value established on the basis 
of the sequence, namely Mr 19 824; however the 
apoferritin oligomer (24 subunits) calculated from 
this data is M, 476 000 which is in good agreement 
with X-ray crystallographic studies [4]. 
We can also draw some conclusions on the reasons 
which have led to such a long delay in establishing 
the amino acid sequence of this protein. Since 9 of 
the 11 arginine residues are located in the first 75 
residues whereas the last 2 are in positions 153 and 
168, cleavage of the protein by trypsin after citra- 
conylation of the lysine residues (which proved to be 
essential in order to get reasonable yields of peptides, 
as for staphylococcal protease and chymotryptic 
digestion) leaves us with a large region of the mole- 
cule for which no overlaps with other digests were 
possible except in the N-terminal region (residues 
76-104). Further it proved extremely difficult to 
separate the large arginyl peptide T9 from the highly 
aggregating T2-T4 mixture. The use of CNBr cleavage 
was also handicapped by the fact that the largest 
CNBR peptide CNl (residues l-68) is N-terminal 
blocked by an acetyl group, CN2 (residues 69-96) is 
of almost the same size as CN4 (residues 144-174), 
and the N-terminal Gln tends to cyclise rapidly, and 
CN3 (residues 97-143) aggregates as do all of the 
CNBr peptides and is difficult to separate from CNl . 
We were able to obtain all of the CNBr peptides in 
pure form towards the end of the sequence determina- 
tion and the N-terminal sequence of CN3 [ 141 and 
CN4 [ 141 as well as the tryptic peptides of CN4 were 
helpful in confirming the C-terminal sequence of the 
subunit. 
The distribution of aromatic and hydrophobic 
amino acid residues is quite interesting. Thus 9 of the 
15 aromatic residues are present in the N-terminal 
sequence from Tyr 8-Phe 5 1 and 15 of the Ala, Val, 
Leu and Ile residues of a total of 55 are also present 
in this sequence. There is also a tendency for aromatic 
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residues to be present in clusters either together or 
separated by one other residue. We have already com- 
mented on the somewhat unusual distribution of&g 
in the sequence. However, we may also note a rather 
pronounced tendency for charged residues to occur in 
clusters, the most notable being the sequence Glu- 
Glu-Lys-Arg-Glu (residues 54-60) and Asp-Glu- 
Glu (residues 135-137). It should be pointed out ’ 
that if the sequence 53-63 were to be in an a-helical 
conformation then Glu 53 and Glu 56 as well as Glu 
57, Glu 60 and Glu 63 would be disposed on the 
same face of the helix, forming 2 potential metal 
binding sites. The same would be true of Asp 127 and 
Glu 130. Since carboxyl groups have been implicated 
from chemical modification studies in iron binding 
and in the catalysis of iron oxidation and deposition 
by the protein [29] and since a part of the putative 
catalytic (iron oxidation) site has been isolated, iden- 
tified as the peptide 53-59 [30] it will be interesting 
to see whether the X-ray analysis of the structure 
confirms that the site of initial iron oxidation is in 
this region of the molecule. 
The total number of amides is 17 (6 Asn and 11 
Gln) giving a total of 27 0 and y carboxyls (12 Asp 
and 15 Glu). This is in good agreement with the num- 
ber found by measurement of NHa liberated on acid 
hydrolysis and with the results of chemical modifica- 
tion [29,3 l] although the results in [3 l] are in much 
better accord than our own data [ 18,291. 
On the basis of the primary structure we have 
attempted to predict the secondary structure of the 
protein using the methods in [32]. The results indicate 
o-helix from residues 9-18,39-48,50-72,74-83, 
93-119,128-147 and 163-I 72 with p-turns at posi- 
tions 7-l 1,38-43,70-76,84-90 and 123-128 
together with some evidence for P-pleated sheets in 
positions 2-10,15-39,46-52 and 147-159. 
The correlation of the amino acid sequence with 
the three-dimensional structure [ 11 ,I 21 will be dis- 
cussed in greater detail in [33]. We note that the primary 
structure presented here seems to be most compatible 
with one of the two connectivities proposed by the 
Sheffield group in which the helices are joined in the 
order A-B-(loop)-C-D-P-E [ 121. This order is 
also in good agreement with the secondary structure 
predictions since, with the exception of the predic- 
tion of only a small part of helix A, and the lack of 
helix P, helices B-E are predicted at about the posi- 
tions expected from the X-ray data. The fitting of the 
sequence to the electron density map calculated at a 
326 
resolution of 0.28 nm [ 121 is well advanced and will 
be reported in [33]. 
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